Physician profile
David L Saint
NPI 1801841861
$6,468.85
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,821 · 2020: $1,237 · 2021: $650 · 2022: $405 · 2023: $311 · 2024: $45.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $3,443.59 | 2019-2021 | |
| Abbott Laboratories | $1,024.17 | 2019-2022 | |
| Abiomed | $559.25 | 2019-2021 | |
| Artivion, INC. | $400.00 | 2021 | |
| Medtronic, INC. | $227.22 | 2022-2024 | Corevalve Evolut R, Onyx Frontier |
| Cardiac Dimensions, INC. | $198.91 | 2023 | |
| Biom'Up Sa | $141.02 | 2019 | |
| Edwards Lifesciences Corporation | $124.71 | 2019-2022 | |
| Heartflow, INC. | $86.25 | 2022 | |
| Atricure, INC. | $73.61 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $63.67 | 2019-2020 | |
| Dilon Technologies, INC. | $30.52 | 2023 | Hemoblast Bellows |
| Getinge USA Sales, LLC | $29.54 | 2022 | |
| Portola Pharmaceuticals, LLC | $20.47 | 2019 | |
| Wound Management Technologies, INC | $20.07 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $13.87 | 2021 | |
| W. L. Gore & Associates, INC. | $11.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Saint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.